조덕 (성균관대학교 의과대학, 삼성서울병원)님 | 한빛사연구자 > 한빛사

성균관대학교 의과대학, 삼성서울병원

최종업데이트 2024.12.10.

Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma
- Exp. Hematol. Oncol., 29 September 2025 | https://doi.org/10.1186/s40164-025-00707-7
- 2025-09
- 의약학
- 한빛사논문
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
- Blood, Dec 09 2024, blood.2024025673 | https://doi.org/10.1182/blood.2024025673
- 2024-12
- 의약학
- 한빛사논문
Integrative Magneto-Microfluidic Separation of Immune Cells Facilitates Clinical Functional Assays
- Small, 2023 Jun 27;e2302809 | https://doi.org/10.1002/smll.202302809
- 2023-06
- 바이오·의료융합
- 한빛사논문
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
- Cell. Mol. Immunol., 18, pages1652–1661 (2021). https://doi.org/10.1038/s41423-021-00686-9
- 2021-07
- 의약학
- 한빛사논문
The Anti-Canine Distemper Virus Activities of Ex Vivo-Expanded Canine Natural Killer Cells
- Vet. Microbiol., 3 February 2015 | doi:10.1016/j.vetmic.2015.01.021
- 2015-02
- 의약학
- 구.농수식품

연구자 ID

저자논문